DRKS00029615招募中不适用
99mTc-PSMA SPECT/CT as a predictor of response to 177Lu-PSMA therapy in patients with metastatic castration-resistant prostate cancer.
Vivantes - Netzwerk für Gesundheit GmbH, Institut für Nuklearmedizin0 个研究点目标入组 30 人开始时间: 2023年9月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Male
入选标准
- •Confirmed mCRPC, progressive disease, good general condition, exhausted recommended therapeutic options, recommendation of an interdisciplinary tumor conference.
排除标准
- •Contradiction to the inclusion criteria.
研究者
相似试验
已完成
不适用
Comparison of the detection rate in SPECT/CT with NaI detectors and SPECT/CT with CZT semiconductor detectors used in bone scintigraphy - RAD324Bone metastasesC79.5Secondary malignant neoplasm of bone and bone marrowDRKS00011421niversitätsklinikum Magdeburg48
进行中（未招募）
1 期
MET-PET-study - A comparative study of Tc-99m- sestamibi SPECT/ldCT and C-11-L-Methionin PET/diagnostic CT and their ability to locate paratyroid adenomas preoperatively.EUCTR2013-004886-14-DKDep. Nuclear medicine, Odense university hospital60
招募中
不适用
PET scan for measuring response in lymphoma of braiCTRI/2021/05/033776Tata Memorial Centre Mumbai
已完成
不适用
uclear medicine imaging study for ankylosing spondylitis diagnosis and therapyDiseases of the musculo-skeletal system and connective tissueKCT0001307Seoul Metropolitan Government Seoul National University Boramae Medical Center20
招募中
不适用
Evaluation of the use of PET/CT in Adenoid Cystic Carcinoma (ADC)Adenoid Cystic CarcinomaRBR-84nmnm9Eduardo Nóbrega Pereira Lima